Changes in reward-induced brain activation in opiate addicts.
Many studies indicate a role of the cerebral dopaminergic reward system in addiction. Motivated by these findings, we examined in opiate addicts whether brain regions involved in the reward circuitry also react to human prototypical rewards. We measured regional cerebral blood flow (rCBF) with H(2)(15)O positron emission tomography (PET) during a visuo-spatial recognition task with delayed response in control subjects and in opiate addicts participating in a methadone program. Three conditions were defined by the types of feedback: nonsense feedback; nonmonetary reinforcement; or monetary reward, received by the subjects for a correct response. We found in the control subjects rCBF increases in regions associated with the meso-striatal and meso-corticolimbic circuits in response to both monetary reward and nonmonetary reinforcement. In opiate addicts, these regions were activated only in response to monetary reward. Furthermore, nonmonetary reinforcement elicited rCBF increases in limbic regions of the opiate addicts that were not activated in the control subjects. Because psychoactive drugs serve as rewards and directly affect regions of the dopaminergic system like the striatum, we conclude that the differences in rCBF increases between controls and addicts can be attributed to an adaptive consequence of the addiction process.
Martin-Soelch
C
C
Paul Scherrer Institute, PET Program, CH-5232 Villigen, Switzerland. Chantal.Martin@unibas.ch
Chevalley
A F
AF
Künig
G
G
Missimer
J
J
Magyar
S
S
Mino
A
A
Schultz
W
W
Leenders
K L
KL
D000328:Adult; D001921:Brain / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology; D001931:Brain Mapping; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D004644:Emotions / Q000187:drug effects / Q000502:physiology; D030141:Feedback, Psychological / Q000187:drug effects / Q000502:physiology; D007839:Functional Laterality / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008297:Male; D009294:Narcotics / Q000009:adverse effects*; D009434:Neural Pathways / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology; D009483:Neuropsychological Tests; D009293:Opioid-Related Disorders / Q000378:metabolism* / Q000503:physiopathology; D010775:Photic Stimulation; D011597:Psychomotor Performance / Q000187:drug effects / Q000502:physiology; D012201:Reward; D014055:Tomography, Emission-Computed
D009294:Narcotics